var data={"title":"Sorbitol: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Sorbitol: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6978?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=sorbitol-drug-information\" class=\"drug drug_general\">see &quot;Sorbitol: Drug information&quot;</a> and <a href=\"topic.htm?path=sorbitol-patient-drug-information\" class=\"drug drug_patient\">see &quot;Sorbitol: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1049964\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Laxative, Hyperosmolar</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Laxative, Osmotic</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1049961\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=sorbitol-drug-information\" class=\"drug drug_general\">see &quot;Sorbitol: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatrics:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Constipation:</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: 70% solution: </p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Manufacturer's labeling: Children &ge;12 years and Adolescents: Usual dose: 30 to 45 mL once daily as needed; maximum dose: 60 mL/dose; higher daily doses (60 to 90 mL in divided doses) may be necessary in some patients. <b>Note:</b> Consult product-specific labeling for detailed information.</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Alternate dosing: Limited data available: Infants, Children and Adolescents: 1 to 3 mL/kg/day in divided doses, once or twice daily (Wyllie 2011). Usual range in adolescents:  30 to 90 mL/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Rectal enema: 25% to 30% solution:  </p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Children 2 to &lt;12 years: 30 to 60 mL once daily as needed </p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Children &ge;12 years and Adolescents: 120 mL once daily as needed </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Fecal disimpaction, slow disimpaction:</b>  Oral: 70% solution: Limited data available: Infants, Children, and Adolescents: 2 mL/kg twice daily for 7 days (Pashankar 2005; Wyllie 2011)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Toxic ingestion, adjunct with charcoal:</b> Children and Adolescents: Oral: 35% solution: 4.3 mL/kg; <b>Note:</b> Current guidelines recommend limiting use to a single dose administered with the initial charcoal dose of 1 g/kg (AACT/EAPCCT 2004). </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Hyperosmotic laxative (as single dose, at infrequent intervals): </b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: 70% solution: 30 to 150 mL </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Rectal enema: 25% to 30% solution: 120 mL </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Transurethral surgical procedures:</b> Irrigation: Topical: 3% to 3.3% as transurethral surgical procedure irrigation </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222403\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Irrigation: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 3% (3000 mL); 3.3% (2000 mL, 4000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 70% (30 mL, 473 mL, 474 mL, 480 mL, 3840 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Rectal: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 70% (473 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222389\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222417\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Irrigation solution: Avoid storage in temperatures &gt;150&deg;F; do not freeze.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Oral solution: Store at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); do not freeze; below 15&deg;C (59&deg;F) cloudiness and thickening may occur; warming will restore clarity and fluidity without affecting product quality. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1049966\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral: Hyperosmotic laxative; sweetening agent (OTC product: FDA approved in ages &ge;12 years and adults); has also been used to facilitate the passage of  charcoal-toxin complex through the intestinal tract </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Rectal: Hyperosmotic laxative (OTC product: FDA approved in ages &ge;2 years and adults); refer to product specific information for detail on ages for pediatric patients</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Irrigation solution: Genitourinary irrigant in transurethral prostatic resection or other transurethral resection or other transurethral surgical procedures; irrigant for indwelling catheter to maintain patency (FDA approved in adults) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222447\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cardiovascular: Edema</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Electrolyte depletion, hyperglycemia, hypovolemia, lactic acidosis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Abdominal distress, diarrhea, nausea, vomiting, xerostomia</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222409\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Anuria (for irrigation)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>OTC labeling</b>: When used for self-medication, do not use for longer than 7 days or when abdominal pain, nausea, or vomiting is present.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222393\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Fluid/electrolyte imbalance: Large volumes may result in fluid overload and/or electrolyte changes.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Cardiopulmonary disease: Use with caution in patients with severe cardiopulmonary disease.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Renal impairment: Use with caution in patients with renal impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Unable to metabolize sorbitol: Use with caution in patients unable to metabolize sorbitol.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25956041\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Excessive amounts of sorbitol may cause hypernatremic dehydration in pediatric patients; use with caution in infants; other causes of constipation should be evaluated prior to initiating therapy.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300074\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6223042\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12801&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Calcium Polystyrene Sulfonate: Sorbitol may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. More specifically, concomitant use of these agents may increase the risk for intestinal necrosis. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">LamiVUDine: Sorbitol may decrease the serum concentration of LamiVUDine.  Management: When possible, avoid chronic coadministration of sorbitol-containing solutions with lamivudine, but if this combination cannot be avoided, monitor patients more closely for possible therapeutic failure associated with decreased lamivudine exposure.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sodium Polystyrene Sulfonate: Sorbitol may enhance the adverse/toxic effect of Sodium Polystyrene Sulfonate. More specifically, concomitant use of these agents may increase the risk for intestinal necrosis. <i> Risk X: Avoid combination</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222399\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F14079771\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1049963\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Stool output, fluid status, serum electrolytes (changes may be delayed due to slow absorption) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222392\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">A polyalcoholic sugar with osmotic cathartic actions</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222408\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: Rectal: 0.25-1 hour </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Oral, rectal: Poor </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Primarily hepatic to fructose</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F222411\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sorbitol Irrigation)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3% (3000 mL): $25.83</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3.3% (2000 mL): $7.24</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sorbitol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">70% (474 mL): $4.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sorbitol Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">70% (473 mL): $3.83</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6038830\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Agarol (CH);</li>\n      <li>Ardeanutrisol SO (CZ);</li>\n      <li>Cystosol (SE);</li>\n      <li>klysma Sorbit (DE);</li>\n      <li>Medevac (AU);</li>\n      <li>Progras (AR);</li>\n      <li>Resulax (SE);</li>\n      <li>Sladial (HR);</li>\n      <li>Sorbilande (IT);</li>\n      <li>Sorbilax (AU);</li>\n      <li>Sorbit Fresenius (AT);</li>\n      <li>Sorbit Leopold (AT);</li>\n      <li>Sorbit Mayrhofer (AT);</li>\n      <li>Sorbitol Aguettant (FR);</li>\n      <li>Sorbitol Baxter (LU);</li>\n      <li>Sorbitol Delalande (BE, FR);</li>\n      <li>Sorbitol-Infusionslosung (DE);</li>\n      <li>Syn M.D. (BE, CH, LU)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists, &ldquo;Position Paper: Cathartics,&rdquo; <i>J Toxicol Clin Toxicol</i>, 2004, 42(3):243&ndash;53.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sorbitol-pediatric-drug-information/abstract-text/15362590/pubmed\" target=\"_blank\" id=\"15362590\">15362590</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Clinical Toxicology and European Association of Poison Centres and Clinical Toxicologists,&ldquo;Position Statement and Practice Guidelines on the Use of Multi-dose Activated Charcoal in the Treatment of Acute Poisoning,&rdquo; <i>J Toxicol Clin Toxicol</i>, 1999, 37(6):731&ndash;51.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sorbitol-pediatric-drug-information/abstract-text/10584586/pubmed\" target=\"_blank\" id=\"10584586\">10584586</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Charney EB and Bodurtha JN, &ldquo;Intractable Diarrhea Associated With the Use of Sorbitol,&rdquo; <i>J Pediatr</i>, 1981, 98:157-8. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sorbitol-pediatric-drug-information/abstract-text/7452390/pubmed\" target=\"_blank\" id=\"7452390\">7452390</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    H &amp; H solution (sorbitol) [prescribing information]. Brooklyn, NY: H&amp;H Laboratories; June 2013.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    James LP, Nichols MH, and King WD, &ldquo;A Comparison of Cathartics in Pediatric Ingestions,&rdquo; <i>Pediatrics</i>, 1995, 96(2 Pt 1):235-8. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sorbitol-pediatric-drug-information/abstract-text/7630676/pubmed\" target=\"_blank\" id=\"7630676\">7630676</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kumar A, Weatherly MR, and Beaman DC, &ldquo;Sweeteners, Flavorings, and Dyes in Antibiotic Preparations,&rdquo; <i>Pediatrics</i>, 1991, 87(3):352-60.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sorbitol-pediatric-drug-information/abstract-text/2000275/pubmed\" target=\"_blank\" id=\"2000275\">2000275</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pashankar DS. Childhood constipation: evaluation and management.<i> Clin Colon Rectal Surg</i>. 2005;18(2):120-127.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sorbitol-pediatric-drug-information/abstract-text/20011352 /pubmed\" target=\"_blank\" id=\"20011352 \">20011352 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Qualitest solution (sorbitol) [prescribing information]. Huntsville, AL: Qualitest Pharmaceuticals, Inc; February 2006.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wyllie R, Hyams JS, eds. <i>Pediatric Gastrointestinal and Liver Disease: Expert Consult - Online and Print</i>. 4th ed. Philadelphia, PA: Saunders; January 2011.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12801 Version 83.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1049964\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1049961\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F222403\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F222389\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F222417\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1049966\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F222447\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F222409\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F222393\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F25956041\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300074\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F6223042\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F222399\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F14079771\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1049963\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F222392\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F222408\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F222411\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F6038830\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12801|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=sorbitol-drug-information\" class=\"drug drug_general\">Sorbitol: Drug information</a></li><li><a href=\"topic.htm?path=sorbitol-patient-drug-information\" class=\"drug drug_patient\">Sorbitol: Patient drug information</a></li></ul></div></div>","javascript":null}